Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3039% below fair value
$2.30+0.04 (+1.77%)
Close on Nov 18, 2026Market cap $37.86MP/E –Yield –
Sensus Healthcare free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Sensus Healthcare's free cash flow for the twelve months ending Sep 30, 2026 was -$11.53M, down 632.0% year over year. For fiscal 2025 it was $332.00K. The highest annual figure on record is $332.00K in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $332.00K | – |
| FY2024 | Dec 31, 2024 | -$1.11M | – |
| FY2023 | Dec 31, 2023 | -$2.37M | – |
| FY2022 | Dec 31, 2022 | -$1.57M | – |
| FY2021 | Dec 31, 2021 | -$414.00K | – |
| FY2020 | Dec 31, 2020 | -$793.00K | – |
| FY2019 | Dec 31, 2019 | -$2.51M | – |
| FY2018 | Dec 31, 2018 | -$9.42M | – |
| FY2017 | Dec 31, 2017 | -$3.34M | – |
| FY2016 | Dec 31, 2016 | -$1.14M | – |
| FY2015 | Dec 31, 2015 | -$1.54M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.27M | -198.9% |
| Q2 FY2026 | Jun 30, 2026 | -$3.14M | -201.7% |
| Q1 FY2026 | Mar 31, 2026 | -$3.76M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.37M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.29M | -36.6% |
| Q2 FY2025 | Jun 30, 2025 | $3.09M | -26.9% |
| Q1 FY2025 | Mar 31, 2025 | -$2.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$530.00K | -119.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.62M | +739.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.23M | +492.8% |
| Q1 FY2024 | Mar 31, 2024 | -$8.42M | – |
| Q4 FY2023 | Dec 31, 2023 | $2.67M | – |
| Q3 FY2023 | Sep 30, 2023 | $431.00K | -88.2% |
| Q2 FY2023 | Jun 30, 2023 | $713.00K | -61.5% |
| Q1 FY2023 | Mar 31, 2023 | -$6.19M | -303.6% |
| Q4 FY2022 | Dec 31, 2022 | -$10.12M | – |
| Q3 FY2022 | Sep 30, 2022 | $3.66M | +193.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.85M | +37.2% |
| Q1 FY2022 | Mar 31, 2022 | $3.04M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.82M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.25M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.35M | -36.3% |
| Q1 FY2021 | Mar 31, 2021 | -$1.20M | -499.7% |
| Q4 FY2020 | Dec 31, 2020 | -$464.00K | -177.1% |
| Q3 FY2020 | Sep 30, 2020 | -$2.75M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.12M | -64.4% |
| Q1 FY2020 | Mar 31, 2020 | $299.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $601.82K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.94M | – |
| Q2 FY2019 | Jun 30, 2019 | $5.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.13M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.74M | -333.3% |
| Q3 FY2018 | Sep 30, 2018 | -$2.53M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.38M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.77M | – |
| Q4 FY2017 | Dec 31, 2017 | $748.07K | -48.9% |
| Q3 FY2017 | Sep 30, 2017 | -$936.56K | – |
| Q2 FY2017 | Jun 30, 2017 | -$135.15K | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.47M | – |
See a number that looks wrong?